Muñoz A, Zenke M, Gehring U, Sap J, Beug H, Vennström B
Differentiation Programme, EMBL, Heidelberg, FRG.
EMBO J. 1988 Jan;7(1):155-9. doi: 10.1002/j.1460-2075.1988.tb02795.x.
To identify and characterize the hormone-binding domain of the thyroid hormone receptor, we analyzed the ligand-binding capacities of proteins representing chimeras between the normal receptor and P75gag-v-erbA, the retrovirus-encoded form deficient in binding ligand. Our results show that several mutations present in the carboxy-terminal half of P75gag-v-erbA co-operate in abolishing hormone binding, and that the ligand-binding domain resides in a position analogous to that of steroid receptors. Furthermore, a point mutation that is located between the putative DNA and ligand-binding domains of P75gag-v-erbA and that renders it biologically inactive fails to affect hormone binding by the c-erbA protein. These results suggest that the mutation changed the ability of P75gag-v-erbA to affect transcription since it also had no effect on DNA binding. Our data also suggest that hormone-independent activity of P75gag-v-erbA provided a selective advantage to the avian erythroblastosis virus during the original selection for a highly oncogenic strain of the virus.
为了鉴定和表征甲状腺激素受体的激素结合结构域,我们分析了代表正常受体与P75gag-v-erbA(缺乏结合配体能力的逆转录病毒编码形式)之间嵌合体的蛋白质的配体结合能力。我们的结果表明,P75gag-v-erbA羧基末端一半中存在的几个突变共同作用消除了激素结合,并且配体结合结构域位于与类固醇受体类似的位置。此外,位于P75gag-v-erbA假定的DNA和配体结合结构域之间且使其生物学上无活性的一个点突变,并未影响c-erbA蛋白的激素结合。这些结果表明,该突变改变了P75gag-v-erbA影响转录的能力,因为它对DNA结合也没有影响。我们的数据还表明,P75gag-v-erbA的激素非依赖性活性在最初选择该病毒的高度致癌菌株期间为禽成红细胞增多症病毒提供了选择性优势。